Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AVXL
#3370
Anavex Life Sciences
3.2
2
USD
+3.21%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.21%
Monthly Change
-32.21%
6 month change
-64.22%
Year Change
-64.30%
Previous Close
3.1
2
Open
3.1
5
Bid
Ask
Low
3.1
5
High
3.2
2
Volume
44
Markets
US Stock Market
Healthcare
AVXL
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
66.96 M
76.02 M
77.96 M
82.09 M
84.82 M
89.35 M
—
Valuation ratios
Enterprise value
275.43 M
1.21 B
655.41 M
371.05 M
349.57 M
692.62 M
2.2 B
Price to earnings ratio
-1.83
-5.46
—
-10.6
-10.92
-16.48
-56
Price to sales ratio
157.51
-859.29
—
78.32
63.14
174.66
513.19
Price to cash flow ratio
-2.26
-6.82
—
-18.26
-15.39
-19.44
-73.83
Price to book ratio
1.77
1.37
—
3.58
3.94
8
12.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.76
-0.23
-0.31
-0.31
-0.32
-0.45
-0.36
Return on equity %
-0.96
-0.25
-0.34
-0.33
-0.36
-0.49
-0.41
Return on invested capital %
—
-2.1 M
-116.28 K
-47.41 K
-29.92 K
-24.5 K
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-10.08 K
17.52 K
-117.54 K
-860.56
-704.18
-1 182.88
-4 088.32
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-8 602.08
15.72 K
-110.61 K
-733.22
-572.67
-1 067.12
-3 663.49
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.73
15.61
15.59
13.23
9.31
12.7
52.11
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
-0
0
0.04
0.05
0.04
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-2.01
-2.63
—
-0.35
-0.37
-0.46
-0.4
EBIT per share
-2.91
-3.66
—
-0.62
-0.54
-0.55
-0.47
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
2.77
13.18
—
1.89
1.58
1.2
5.23
Net current asset value per share
3.27
14
—
1.93
1.61
1.21
5.26
Tangible book value per share
2.58
13.07
—
1.78
1.44
1.11
4.77
Working capital per share
2.58
13.11
—
1.78
1.44
1.12
4.77
Book value per share
2.58
13.07
—
1.78
1.44
1.11
4.77
News
Is AC Immune (ACIU) Outperforming Other Medical Stocks This Year?
Anavex reports positive preclinical Parkinson’s study results
What's Going On With Anavex Life Sciences Stock On Wednesday? - Anavex Life Sciences (NASDAQ:AVXL)
Anavex Life Sciences at TD Cowen Conference: Promising Alzheimer’s Drug Results
Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?
Anavex Life Sciences appoints Dr. Axel Paeger to board
Anavex Life Sciences (AVXL) Upgraded to Buy: Here's What You Should Know
Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?
Anavex: Negative EU Opinion Leaves Blarcamesine In Regulatory Purgatory (NASDAQ:AVXL)
Earnings call transcript: Anavex Life Sciences beats EPS forecast in Q1 2026
Anavex Stock And Alzheimer's Disease: The Future Never Seems To Be Now (NASDAQ:AVXL)
H.C. Wainwright reiterates Buy rating on Anavex Life Sciences stock